Where does ParcelBio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ParcelBio's 1 recorded funding rounds.

Premier Alternatives

ParcelBio

Drug Discovery · San Francisco, CA · Founded 2023 · Privately Held (backing)

Developer of a programmable technology designed to deliver messenger ribonucleic acid to diverse cell types in the body. ParcelBio is based in San Francisco, CA and was founded in 2023. It was valued at $41.2 million at its seed round in Mar 2026, the last priced event on record. It has raised $13.7 million across 1 recorded round; the latest was a seed round in May 2024.

PMV mark · valuation

$41.2M

Oct 2026

Priced at

its seed round

Mar 2026

Total raised

$13.7M

Last round

Seed Round

May 2024

Cap table — not yet on record

ParcelBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of ParcelBio with a free account

·The complete investor list: 13 names
·Watch ParcelBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about ParcelBio

Where does ParcelBio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ParcelBio's 1 recorded funding rounds.